// App-Quantinova.ai

: Canakinumab Anti-Inflammatory Thrombosis Outcomes Study - CANTOS

Researchers

Presenter

  • Paul M. Ridker

Principal Investigators

  • Anthony A. Bavry

  • Deepak L. Bhatt

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Oncology (ONC)

Disease

  • Tuberculosis

  • Venous thrombosis

  • Diabetes

  • Solid malignancies

Biomarkers

  • High sensitivity C-reactive protein

Drug/Treatment

  • canakinumab (SC)

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Novartis

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved